(19)
(11) EP 4 519 316 A1

(12)

(43) Date of publication:
12.03.2025 Bulletin 2025/11

(21) Application number: 23724717.6

(22) Date of filing: 02.05.2023
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
G01N 33/574(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2827; C07K 2317/24; C07K 2317/51; C07K 2317/70; C07K 2317/76; A61P 35/00; A61K 2039/505; C07K 2317/565; C07K 2317/92; C07K 2317/94
(86) International application number:
PCT/EP2023/061555
(87) International publication number:
WO 2023/213814 (09.11.2023 Gazette 2023/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 02.05.2022 EP 22305654
02.05.2022 WO PCT/EP2022/061718

(71) Applicant: PIERRE FABRE MEDICAMENT
81500 Lavaur (FR)

(72) Inventors:
  • BECK, Alain
    81106 CASTRES (FR)
  • MALISSARD, Martine
    81106 CASTRES (FR)
  • COUSINET, Audrey
    81106 CASTRES (FR)

(74) Representative: Regimbeau 
20, rue de Chazelles
75847 Paris Cedex 17
75847 Paris Cedex 17 (FR)

   


(54) NEW FORMULATION OF ANTI VISTA ANTIBODY